Get started
Omeros CorporationOmeros CorporationOmeros Corporation

Omeros Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

OMER chart


Full chart

OMER upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪585.87 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.30 USD
Net income (FY)
‪−117.81 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪55.36 M‬
Beta (1Y)
0.62

Employees


Employees (FY)
198
Change (1Y)
+2 +1.02%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−883.43 K‬ USD

About Omeros Corporation


Sector
Health Technology
CEO
Gregory A. Demopulos
Headquarters
Seattle
Website
omeros.com
Founded
1994
FIGI
BBG000JLP4B4
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

OMER news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

OMER highest yielding bonds


OMER5029812
Omeros Corporation 5.25% 15-FEB-2026
Yield to maturity
9.47%
Maturity date
Feb 15, 2026

Explore more bonds 

Frequently Asked Questions


The current price of OMER is 10.00 USD — it has decreased by −1.09% in the past 24 hours. Watch Omeros Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omeros Corporation stocks are traded under the ticker OMER.
OMER stock has risen by 33.33% compared to the previous week, the month change is a 29.87% rise, over the last year Omeros Corporation has showed a 216.46% increase.
We've gathered analysts' opinions on Omeros Corporation future price: according to them, OMER price has a max estimate of 36.00 USD and a min estimate of 16.00 USD. Watch OMER chart and read a more detailed Omeros Corporation stock forecast: see what analysts think of Omeros Corporation and suggest that you do with its stocks.
OMER reached its all-time high on Aug 18, 2015 with the price of 30.23 USD, and its all-time low was 0.92 USD and was reached on Oct 16, 2023. View more price dynamics on OMER chart.
See other stocks reaching their highest and lowest prices.
OMER stock is 6.31% volatile and has beta coefficient of 0.62. Track Omeros Corporation stock price on the chart and check out the list of the most volatile stocks — is Omeros Corporation there?
Today Omeros Corporation has the market capitalization of ‪585.87 M‬, it has decreased by −12.54% over the last week.
Yes, you can track Omeros Corporation financials in yearly and quarterly reports right on TradingView.
Omeros Corporation is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
OMER earnings for the last quarter are −0.56 USD per share, whereas the estimation was −0.70 USD resulting in a 20.57% surprise. The estimated earnings for the next quarter are −0.69 USD per share. See more details about Omeros Corporation earnings.
Omeros Corporation revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
OMER net income for the last quarter is ‪−32.23 M‬ USD, while the quarter before that showed ‪−56.04 M‬ USD of net income which accounts for 42.48% change. Track more Omeros Corporation financial stats to get the full picture.
No, OMER doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 198.00 employees. See our rating of the largest employees — is Omeros Corporation on this list?
Like other stocks, OMER shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omeros Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omeros Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omeros Corporation stock shows the buy signal. See more of Omeros Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.